News | EVA Pharma

Latest News

EVA Group and Lilly enter into a partnership in Egypt

EVA Pharma Launches its Immunity Booster Limitless Zinc® Tablets

U.S. Food and Drug Administration (FDA) Approved Remdesivir as the only Treatment for COVID-19

EVA Pharma Launches the First Egyptian Generic for Type 2 Diabetes Treatment Diaflozimet® Tablets

EVA Pharma starts export of COVID-19 Antiviral Avipiravir® Worldwide

FDA Broadens Emergency Use Authorization for Remdesivir to Include All Hospitalized Patients for Treatment of COVID-19

Two Egyptian-Manufactured Medicines are Soon Entering Europe and Canada

EVA Pharma Talent Academy Equips 3 Thousands Pharmacy Students for the Job Market

EVA Pharma Releases 500 Thousand Packs of the Analgesic and Antipyretic Drug Paracetamol under the Trade Name Stopadol®

The Supreme Committee for Viruses Recognizes EVA Pharma as a Partner in the Eradication of Virus C in Egypt

EVA Pharma Explores the Manufacturing of COVID-19 Vaccines with European and American Companies

The Telegraph announced that “Sofosbuvir” and “Daclatasvir” Produced by EVA Pharma are reducing Coronavirus Death Rate